Multaq Sucks

Quote

anonymous

Guest
How do they expect anyone to sell this piece of sh*t overpriced drug Multaq? They are becoming desperate now pushing VERNE. That is what reps want…to record a video of themselves appearing desperate and awkward to send out to highly regarded cardiologists.
 




anonymous said:
How do they expect anyone to sell this piece of sh*t overpriced drug Multaq? They are becoming desperate now pushing VERNE. That is what reps want…to record a video of themselves appearing desperate and awkward to send out to highly regarded cardiologists.
Click to expand...
Reps at launch meeting thought drug should be pulled from market
 












I was not aware of Sanofi having a GLP-1 prior to a week or so ago. I came across talk of it.

They had forked over a ton of money upfront back in like 2015 to partner with Hanmi Pharma then pulled out of the deal in 2019 when new CEO joined and cut diabetes and cardio R&D.

The GLP-1 never made it to market. Not sure what the status of it is but Sanofi no longer a partner for it.
 




anonymous said:
I was not aware of Sanofi having a GLP-1 prior to a week or so ago. I came across talk of it.

They had forked over a ton of money upfront back in like 2015 to partner with Hanmi Pharma then pulled out of the deal in 2019 when new CEO joined and cut diabetes and cardio R&D.

The GLP-1 never made it to market. Not sure what the status of it is but Sanofi no longer a partner for it.
Click to expand...

This just screams typical sanofi. Their pipeline isn't looking as good as they hoped. So many things are failing in the later stages. There's barely anything left. Very few oncology, no more MS, rheum has a few dozen, rare/rare blood don't have a lot going on, and then dupi. Which will lose its patent in what, 5 years?
 








anonymous said:
I was not aware of Sanofi having a GLP-1 prior to a week or so ago. I came across talk of it.

They had forked over a ton of money upfront back in like 2015 to partner with Hanmi Pharma then pulled out of the deal in 2019 when new CEO joined and cut diabetes and cardio R&D.

The GLP-1 never made it to market. Not sure what the status of it is but Sanofi no longer a partner for it.
Click to expand...
 








Downsized 5 years ago, glad to see all the cost cutting measures that the CEO has done has worked wonders on the stock price $48 , lower now than when I was downsized a job well done.
Amazing how the French continue to stick with somebody that burns and slashes and accounted for no shareholder value.
 












anonymous said:
I was not aware of Sanofi having a GLP-1 prior to a week or so ago. I came across talk of it.

They had forked over a ton of money upfront back in like 2015 to partner with Hanmi Pharma then pulled out of the deal in 2019 when new CEO joined and cut diabetes and cardio R&D.

The GLP-1 never made it to market. Not sure what the status of it is but Sanofi no longer a partner for it.
Click to expand...
https://professionals.optumrx.com/c...thdrawls/drugwithdrawal_adlyxin_2023-0117.pdf
 




Top Bottom
Back
Quote